Zusammenfassung
Hormone der Hypophyse und des Hypothalamus sind die zentralen Steuerungshormone für endokrine Drüsen und somatische Körperfunktionen. So regeln einige Hypophysenhormone die periphere Hormonproduktion in Schilddrüse, Nebennierenrinde und Gonaden, andere steigern Wachstum, Laktation, peripheren Gefäßtonus und renale Wasserrückresorption. Die Steuerung der hypophysären Hormonfreisetzung erfolgt einerseits zentral durch die übergeordneten Releasinghormone und Hemmstoffe des Hypothalamus, andererseits bei einigen Hypophysenhormonen durch die peripheren Hormone der endokrinen Drüsen über eine inhibitorische Feedbackregulation.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Al-Inany HG, Abou-Setta AM, Aboulghar M (2006): Gonadotrophin-releasing hormone antagonists for assisted conception. Cochrane Database Syst Rev. 2006 Jul 19; 3: CD001750.
De Mouzon J, Allavena E, Schmitt C, Frappe M (2004): In vitro fertilization in France: economic aspects and influence of the gonadotropin choice (urinary vs. recombinant) on cost. Gynecol Obstet Fertil 32: 508–518. [Article in French].
Frydman R, Howles CM, Truong F (2000): A double-blind, radomized study to compare recombinant human follicle stimulating hormone (FSH; Gonal-F) with highly purified urinary FSH (Metrodin HP) in women undergoing assisted reproductive techniques including intracytoplasmic sperm injection. The French Multicentre Trialists. Hum Reprod 15: 520–525.
International Recombinant Human Chorionic Gonadotropin Study Group (2001): Induction of ovulation in World Health Organization group II anovulatory women undergoing follicular stimulation with recombinant human follicle-stimulating hormone: a comparison of recombinant human chorionic gonadotropin (rhCG) and urinary hCG. Fertil Steril 75: 1111–1118.
Liu H, Bravata DM, Olkin I, Nayak S, Roberts B, Garber AM, Hoffman AR (2007): Systematic review: the safety and efficacy of growth hormone in the healthy elderly. Ann Intern Med 146: 104–115.
Melmed S (2006): Acromegaly. N Engl J Med 355: 2558–2573.
National Institute for Clinical Excellence (NICE) (2002): Guidance on the use of human growth hormone (somatropin) in children with growth failure. Technology Appraisal No. 42. Internet: www.nice.org.uk/page.aspx?o=TA042guidance
National Institute for Clinical Excellence (NICE) (2003): Human growth hormone (somatropin) in adults with growth hormone deficiency. Technology Appraisal 64. Internet: www.nice.org.uk/page.aspx?o=TA064guidance
Savage MO, Drake WM, Carroll PV, Monson JP (2004): Transitional care of GH deficiency: when to stop GH therapy. Eur J Endocrinol 151 Suppl 1: S61–65.
Striegel H, Simon P (2007): Doping: High-Tech-Betrug im Sport. Internist: 48: 737–742.
Van Wely M, Kwan I, Burt AL, Thomas J, Vail A, Van Der Veen F, Al-Inany HG (2011): Recombinant versus urinary gonadotrophin for ovarian stimulation in assisted reproductive technology cycles. Cochrane Database Syst Rev. 2011 Feb 16; 2: CD005354.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Schwabe, U. (2011). Hypophysen- und Hypothalamushormone. In: Schwabe, U., Paffrath, D. (eds) Arzneiverordnungs-Report 2011. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-21992-4_29
Download citation
DOI: https://doi.org/10.1007/978-3-642-21992-4_29
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-21991-7
Online ISBN: 978-3-642-21992-4
eBook Packages: Medicine (German Language)